Budimex Group Presentation for investors for 1Q 2008
|
|
- Barnaby McGee
- 6 years ago
- Views:
Transcription
1 Budimex Group Presentation for investors for 1Q 2008
2 Our strategy 40 years on the market Building long term value backlog value significant growth and structure change solid platform for future growth our goals: high quality service satisfaction of clients comfort of users profitability improvement backlog growth turnover growth shareholders value 2
3 Structure of the Group Budimex Group CONSTRUCTION BUSINESS Budimex Dromex S.A. Mostostal Kraków S.A. Sprzęt Transport Sp. z o.o. (designed for disposal) REAL ESTATE BUSINESS Budimex Inwestycje Sp. z o.o. Budimex Nieruchomości Sp. z o.o. (J.V.) OTHER ACTIVITIES Unibud Sp. z o.o. Companies consolidated with equity method 3
4 Description of the business Budimex Group CONSTRUCTION BUSINESS Infrastructure Construction of roads, highways, Renovations of existing roads, Construction of bridges. REAL ESTATE BUSINESS Residential development Development of residential property (flats). OTHER ACTIVITIES Timber frame houses Production and development of timber frame houses. General construction Residential construction, Non-residential general construction (office buildings, shopping malls, plants), Airports. Ecological Construction of sewage treatment plants, Canalization systems. Rental activity Rental of investment property to external clients. Operating one commercial parking lot. Other services Operating one hotel in Poland. Other activity (equity pick-up) Electro installation company (Elektromontaż Poznań S.A.), Production of switchboards (Elektromontaż Poznań S.A.), Highway licences (Autostrada Południe). 4
5 Stock exchange performance 1Q 2008 Warsaw Stock Exchange performance 1Q ,00% 105,00% 100,00% 95,00% 90,00% 85,00% 80,00% 75,00% WIG - construction WIG Budimex [PLN/share] 5
6 Market capitalization as at 31 March 2008 Capitalization as at vs competitors PBG Polimex Mostostal Siedlce Polaqua Budimex Mostostal Zabrze Mostostal Warszawa Erbud 6
7 Construction market in Poland Dynamics of the production ,0% 25,0% 20,0% 15,0% 10,0% 5,0% 0,0% -5,0% -10,0% -15,0% Dynamics of construction production ,1% 17,5% 15,7% 17,4% 12,6% 5,6% 7,4% 0,6% 1,1% -0,2% ,9% Q ,3% -5,9% -8,0% -8,0% -12,0% Dynamics of construction production Dynamics of Budimex Group sales 7
8 Budimex Group Results 1Q 2008
9 Financial highlights mln PLN 1Q Q 2007 Sales % change 1Q 2008 vs. 1Q ,2% Gross margin as % of sales 5,7% 5,2% Cost of sales and overheads as % of sales -6% -5% Result on sales Other operating activity EBIT Financial activity Gross profit Net profit Capital Expenditure Construction backlog (as at 31 March) Presales of flats value Land Bank (k m2 of flats) (as at 31 March) 255 9
10 Result by segments - sales sales 1Q sales 1Q 2007 Construction business Real estate business Other activities Elimination of internal transactions * TOTAL * mainly Budimex Dromex (Construction segment) sales to Real Estate segment Construction business Real estate business Other activities Elimination of internal transactions * TOTAL 10
11 Result by segments - EBIT EBIT 1Q Construction business Real estate business Other activities Elimination of internal transactions * TOTAL EBIT 1Q * mainly Budimex Dromex (Construction segment) margin on sales to Real Estate segment Construction business Real estate business Other activities Elimination of internal transactions * TOTAL 11
12 Budimex Group Construction segment
13 Construction segment Financial highlights mln PLN 1Q Q 2007 Sales % change 1Q 2008 vs. 1Q % EBITDA as % of sales 0,7% -1,7% EBIT as % of sales 0,1% -2,5% Gross Profit Net profit Capital Expenditure Construction backlog (as at 31 March)
14 Construction segment Sales structure Sales structure by type of works 22% 1Q % 14% 32% 1Q % 25% 60% General construction - residential General construction - non residential Infrastructure construction Other sales residential: 1Q2007 1Q2008 internal: 34% 45% external: 66% 55% Sales structure by markets 41% General construction - residential General construction - non residential Infrastructure construction Other sales 9% 1Q % 1Q % 0% 87% 94% Polish Market German Market Eastern Markets Polish Market German Market Eastern Markets 14
15 Construction segment Backlog structure Backlog structure by type of works 3% 31 III % 31 III % 20% 43% 45% 51% 26% General construction - residential General construction - non residential Infrastructure construction Others (German market) Budimex Group backlog General construction - residential General construction - non residential Infrastructure construction Others (German market) residential including: internal backlog: 21% residential including: internal backlog: 44% external backlog: 79% external backlog: 56% III III 2008 Contracts with value > 1mln PLN III 2007 III 2008 number of contracts average value (mln PLN) Budimex Dromex backlog value to be realized in 2008: mln PLN (including backlog with gross margin 0 : 113 mln PLN) 15
16 Construction segment Contracts signed structure Contracts signed structure by type of works 4% 1Q % 3% 0% 1Q % 50% 37% 61% General construction - residential General construction - non residential Infrastructure construction Others (German market) Contracts signed by Budimex Group General construction - residential General construction - non residential Infrastructure construction Others (German market) residential including: internal contracts signed: 0% Q Q 2008 Budimex Dromex S.A. 1Q Q 2008 number of contracts signed 11 4 average value (mln PLN)
17 Budimex Group Real Estate segment
18 Real Estate segment Financial highlights mln PLN 1Q Q 2007 Sales % change 1Q 2008 vs. 1Q % EBITDA as % of sales 22% 26% EBIT as % of sales 21% 26% Gross Profit Net profit Presales Land Bank (k m2 of flats) (as at 31 March) % of J.V 1Q Q 2007 Sales % change 1Q 2008 vs. 1Q % Presales Presales (volume of flats) Land Bank (k m2 of flats) (as at 31 March)
19 Real Estate segment Notary sales and presales structure by city Notary sales of flats structure 31% 1Q mln PLN 1Q mln PLN 16% 49% 42% 53% Warsaw Cracow Poznań 9% Warsaw Cracow Poznań 22% 1Q % Presales of flats structure 1Q mln PLN 42 mln PLN 0% 1% 77% Warsaw Cracow Poznań 99% Warsaw Cracow Poznań 19
20 Real Estate segment Presales of flats Presales volume of flats (incl. 100% of J.V.) 1Q Q Q Q Q
21 Real Estate segment Land bank Land bank ageing (k m 2 of flats), average flat is 59 m 2 (incl. 50% of J.V.) Land bank geographical structure (k m 2 of flats) (incl. 50% of J.V.) 10% 25% 65% Warsaw Cracow Poznań 21
22 Real Estate segment Land bank Land bank ageing (k m 2 of flats), average flat is 59 m 2 (incl. 100% of J.V.) Land bank geographical structure (k m 2 of flats) (incl. 100% of J.V.) 10% 26% 64% Warsaw Cracow Poznań 22
23 Budimex Group Other Activity
24 Other Activity Financial highlights mln PLN 1Q Q 2007 Sales % change 1Q 2008 vs. 1Q % EBITDA as % of sales -3% -15% EBIT as % of sales -2% -18% Gross Profit Net Profit
25 Other Activity Sales structure Sales structure by country 1Q Q % 19% 7% 10% 4% 68% 10% 64% Germany Poland U.K. Other countries Germany Poland U.K. Other countries Timber-frame houses backlog as at 31 March 2008 volume German British Polish Other market 25
ŚCIŚLE POUFNE. The Company's presentation
The Company's presentation Warsaw, May 2017 Key figures #1 Leader of the market of reinforced concrete prefabricated elements in Poland 4 plants manufacturing reinforced concrete prefabricated elements
More information1Q 2015 Results A Positive Start to 2015
1Q 2015 Results Main Events Operating Results Order Backlog Financial Performance Update on Disposal 1Q 2015 Results A Positive Start to 2015 Rome - May 14, 2015 1Q 2015 Main Backlog Events 1Q 2015 Results
More informationSummary of Results for the First Half of FY2015/3
Summary of Results for the First Half of FY2015/3 November 10, 2014 Tokyu Corporation (9005) http://www.tokyu.co.jp/ Contents Ⅰ.Executive Summary 2 Ⅱ.Conditions in Each Business 5 Ⅲ.Details of Financial
More information1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes
1Q 2015 Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes Forward-Looking Statements and Copyright This Presentation includes and is based, inter alia, on forward-looking information and statements
More informationM e d i a s e t G r o u p
M e d i a s e t G r o u p 11 th May 2004 2004 First Quarter Results M e d i a s e t G r o u p BROADCASTING MEDIASET 2004 1Q 24 Hours Audience Trend Individuals Share Points Vs 1Q 2003 OTHER SATELLITE 44.0%
More informationColoplast A/S. Investor presentation 1H 2005/06
Coloplast A/S Investor presentation 1H 2005/06 2 Coloplast Coloplast products and services help patients achieve greater independence from medical challenges in 4 areas: Ostomy care, continence care, wound
More informationFinancial Results of the Asseco Group for the 1 st quarter of Warsaw, 14 May 2009
Financial Results of the Asseco Group for the 1 st quarter of 2009 Warsaw, 14 May 2009 Agenda Summary of the 1 st quarter of 2009 Nearest plans 2 Financial highlights Consolidated data Sales* Proprietary
More informationQ Investor Kit JANUARY-MARCH 2014
Q1 2014 Investor Kit JANUARY-MARCH 2014 Swedish Match reporting segments Snus and moist snuff Snus (Scandinavia and US) Moist snuff (US) SMPM International Other tobacco products Cigars (US) Chewing tobacco
More informationQ Investor Kit JANUARY-JUNE 2014
Q2 2014 Investor Kit JANUARY-JUNE 2014 Swedish Match reporting segments Snus and moist snuff Snus (Scandinavia and US) Moist snuff (US) SMPM International Other tobacco products Cigars (US) Chewing tobacco
More informationTelekom Austria Group Results for the 1st Quarter May 27, 2003
Telekom Austria Group Results for the 1st Quarter 2003 May 27, 2003 1 Cautionary Statement This presentation contains certain forward-looking statements. Actual results may differ materially from those
More informationThird-quarter results 2013
Third-quarter results 213 Fornebu, 6 November 213 Øyvind Eriksen and Leif Borge Agenda 213 Introduction Øyvind Eriksen Executive chairman Financials Leif Borge President & CFO Q&A Q&A session Øyvind Eriksen
More informationFIRSTQUARTER2018 RESULTSPRESENTATION
FIRSTQUARTER2018 RESULTSPRESENTATION May 14 th 2018 Juan Lladó CEO 1 DISCLAIMER This document has been prepared by Técnicas Reunidas S.A. (the Company) solely for use at presentations held in connection
More informationDIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM
November 28, 2017 DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM Dr. Jürgen Wunram Agenda Diebold Nixdorf AG History and shareholder structure Market trends, strategy and progress of integration Diebold Nixdorf
More informationKAPITALMARKNADSDAG 20 SEPTEMBER Thomas Axelsson, CEO
KAPITALMARKNADSDAG 20 SEPTEMBER 2016 Thomas Axelsson, CEO 1 AGENDA 16.10-16.30 VD har ordet Thomas Axelsson, CEO 16.30-16.50 Clinical relevance of time-lapse Dr. Niels B. Ramsing, Business Unit Time-lapse,
More information1Q2005. Hera Group presentation
1Q2005 Hera Group presentation 1 Y2005 has been characterized by a stream of achievements: Corporate Governance A new BoD was appointed in April. Further penetration of the Hera Gas market: 1,500 new clients
More informationColoplast A/S. Investor Presentation 2005/06
Coloplast A/S Investor Presentation 2005/06 2 Coloplast in brief Coloplast s products and services help patients achieve greater independence from medical challenges in 4 areas, ostomy care, urology &
More informationELICA 2012 Q3 RESULTS. November 14,
ELICA ELICA 1 Q3 12 Highligths Negative market demand, showing better trend compared to previous quarters Group sales over performing in all major markets Cost reduction efforts and continued product innovation
More informationHyundai Motor Company 1 st Quarter 2011 Business Results. April 28, 2011
Hyundai Motor Company 1 st Quarter 2011 Business Results April 28, 2011 Cautionary Statement with Respect to Forward-Looking Statements In the presentation that follows and in related comments by Hyundai
More informationQ Investor Kit JANUARY-MARCH 2013
Q1 2013 Investor Kit JANUARY-MARCH 2013 1 Swedish Match reporting segments Snus and snuff - Swedish snus (Scandinavia and US) - Moist snuff (US) - SMPM International Other tobacco products - Cigars (US)
More informationartnet AG Quarterly Interim Statement for the First Quarter of 2017 artnet AG Quarterly Interim Statement for the First Quarter of 2017
Quarterly Interim Statement for the First Quarter of 2017 Quarterly Interim Statement for the First Quarter of 2017 Table of Contents General Information and Business Activities Economic Development of
More informationEndesa 1Q 2017 Results 09/05/2017
Endesa 1Q 2017 Results 09/05/2017 1. Highlights and key financial figures 2. Endesa s performance in 1Q 2017 market context 3. Financial results 4. Final remarks 2 1. Highlights and key financial figures
More informationartnet AG Quarterly Interim Statement for the First Quarter of 2016 artnet AG Quarterly Interim Statement for the First Quarter of 2016
Quarterly Interim Statement for the First Quarter of 2016 Quarterly Interim Statement for the First Quarter of 2016 for Table of Contents General Information and Business Activities Economic Development
More informationQ Investor Kit January December 2014
Q4 2014 Investor Kit January December 2014 Highlights for Q4 Sales up for all product areas and operating profit from product areas up by 8% Scandinavian hoarding for snus prior to tax increase in January
More informationQ Investor Kit JANUARY-JUNE 2013
Q2 2013 Investor Kit JANUARY-JUNE 2013 1 Swedish Match reporting segments Snus and snuff - Swedish snus (Scandinavia and US) - Moist snuff (US) - SMPM International Other tobacco products - Cigars (US)
More informationMARCH 2014 RESULTS PRESENTATION Madrid, 2014
MARCH 2014 RESULTS PRESENTATION Madrid, 2014 Disclaimer In addition to figures prepared in accordance with IFRS, PRISA presents non-gaap financial performance measures, e.g., EBITDA, EBITDA margin, adjusted
More informationJanuary 30, 2018 Dow Wilson President and Chief Executive Officer
Acquisition of SIRTeX January 30, 2018 Dow Wilson President and Chief Executive Officer This presentation is intended exclusively for investors. It is not intended for use in Sales or Marketing. Forward-Looking
More informationFY2009 First Quarter Financial Results. SUZUKI MOTOR CORPORATION August 3, 2009
FY2009 First Quarter Financial Results SUZUKI MOTOR CORPORATION August 3, 2009 Consolidated: Financial Summary Page 2 FY2009 1Q FY2008 4Q 09/4-6 09/1-3 Change FY2008 1Q 08/4-6 Change (Billion Yen) (A)
More informationFIRST QUARTER 2018 RESULTS 15 MAY 2018 LUCA BETTONTE, CEO
FIRST QUARTER 2018 RESULTS 15 MAY 2018 LUCA BETTONTE, CEO DISCLAIMER This document contains certain forward-looking information that is subject toa number of factors that may influence the accuracy of
More informationBALCHEM CORPORATION. Q Investor Relations Presentation
BALCHEM CORPORATION Q4 2017 Investor Relations Presentation Balchem Corporation Balchem develops, manufactures, and markets specialty ingredients that improve and enhance the health and well being of life
More informationFourth Quarter 2017 NCREIF Indices Review February 9, 2018
Fourth Quarter 2017 NCREIF Indices Review February 9, 2018 Panelist Overview Jeff Fisher NCREIF Data & Research Consultant Doug Herzbrun Global Head of Research CBRE Global Investors Disclaimer Today we
More informationWilliam Demant. Jefferies Healthcare Conf. Nov Søren B. Andersson, VP Investor Relations
William Demant Jefferies Healthcare Conf. Nov. 2017 Søren B. Andersson, VP Investor Relations Agenda General update Key take-aways from November Interim Statement Hearing Devices Outlook 2017 Q&A 2 General
More informationQ2 INVESTOR KIT JANUARY-JUNE 2011
Q2 INVESTOR KIT JANUARY-JUNE 2011 Swedish Match reporting segments Reporting segments following the transaction with STG on October 1, 2010 Snus and snuff - Swedish snus in Scandinavia and US - US moist
More informationForward Looking Information
Vital Signs, Inc. Forward Looking Information Except for historical information discussed, the statements made today are forward-looking statements that involve risks and uncertainties. Investors are cautioned
More informationIncrease in revenues in line with full-year targets (+1.2%) Very strong growth of Oralair exc. USA (+26%) H revenues and results - 24 July 2014
Increase in revenues in line with full-year targets (+1.2%) Very strong growth of Oralair exc. USA (+26%) ( ) H1 2014 revenues and results - 24 July 2014 Forward-looking statement This presentation contains
More information1Q2017 法人說明會 Jun. 9, 2017
1Q2017 法人說明會 Jun. 9, 2017 FE group business Span over 10 major industries Own over 240 companies Established in 1937 9 public listed companies in Taiwan and HK Petrochemical & energy Polyester & synthetic
More informationGROWTH NOW! Franck Riboud
GROWTH NOW! Franck Riboud June 15 h, 2010 Disclaimer This document contains certain forward-looking statements concerning DANONE. Although DANONE believes its expectations are based on reasonable assumptions,
More information1Q 2009 Results Presentation. 12 May 2009
1Q 2009 Results Presentation 12 May 2009 1 Broadcasting 2 MEDIASET 2009 1Q Total Audience TOTAL AUDIENCE (Jan-Mar) * Individuals Δ vs. 2008 +5.3% 15-64 years +5.6% 1Q TV CONSUMPTION (2000-2009) Average
More informationPress release Regulated information
IBA TRADING UPDATE - THIRD QUARTER 2013 Pick up in revenues over H1 2013 due to good order book conversion Company on track to be selected for eight new proton therapy (PT) rooms in 2013 REBIT margin for
More informationPresentation of. Burgdorf, 1 st November 2012
Presentation of Semi-Annual Results 2012/13 Burgdorf, 1 st November 2012 Important Notice The information contained in this document has not been independently verified and no representation or warranty,
More informationColoplast A/S. Investor Presentation Investormøde 16. Januar 2006
Coloplast A/S Investor Presentation Investormøde 16. Januar 2006 2 Defining Coloplast Coloplast products and services help patients achieve greater independence from medical challenges in 5 areas: Ostomy
More informationLeading Intimate Healthcare. Investor presentation Q1 2007/08
Leading Intimate Healthcare Investor presentation Q1 2007/08 1 2 Agenda Introduction to Coloplast Q1 2007/08 in headlines Outlook for 2007/08 Strategic targets Leading intimate healthcare Appendices Q1
More informationSirma Group Holding JSC. Consolidated financial statements for the year ending December 31, 2016
Sirma Group Holding JSC Consolidated financial statements for the year ending December 31, 216 Changes in share prices for the period ending 31.12.216 Last trading price on 3.12 1.189 BGN Change in share
More informationCPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018
CPH Chemie + Papier Holding AG Investor Day Perlen, 13 th September 2018 Agenda 2.00 pm Welcome 2.05 pm Presentation Course of Business 2018 2.50 pm Break 3.00 pm Presentation Perlen Packaging 3.30 pm
More informationBoiron Group confirms its forecasts for year 2008 : sales increase and growth in current operating income.
2008 FIRST QUARTER ACTIVITY IFRS - In thousands of Euros 2007 2007 2008 constant France (1) 0,000 66,087 65,728-0.5% -0.5% Europe excluding France 0,000 33,221 41,346 +24.5% +23.2% North America 0,000
More informationSingapore Exchange Limited 1Q FY2009 Financial Results
Singapore Exchange Limited 1Q FY2009 Financial Results 15 October 2008 Singapore Exchange 1 1Q FY2009 Financial Performance NPAT fell 35% from record 1Q FY2008 Operating profit flat compared to 4Q FY2008
More informationStraumann s net revenues reach CHF 185 million in Q1, driven by continuing double-digit growth in America
Media release Straumann s net revenues reach CHF 185 million in Q1, driven by continuing double-digit growth in America Group net revenue rises 2% (l.c.) as double-digit increases across America offset
More informationFor personal use only
Cochlear Limited Results for the half year ended 31 December 2011 (H1 F12) Chris Roberts, CEO Neville Mitchell, CFO Cochlear Overview Cochlear Limited (ASX:COH): global leader in implantable devices for
More informationValue creation through profitable growth Danske Bank Winter Seminar 2017, Copenhagen Lars Rasmussen, President & CEO
Value creation through profitable growth Danske Bank Winter Seminar 2017, Copenhagen Lars Rasmussen, President & CEO Forward-looking statements The forward-looking statements contained in this presentation,
More informationSecond Quarter and First Half 2011 Conference Call. 29 July, SORIN GROUP Presentation 1
Second Quarter and First Half 2011 Conference Call 29 July, 2011 SORIN GROUP Presentation 1 DISCLAIMER This presentation contains management preliminary estimates and forward-looking statements, including
More information1Q16 FINANCIAL RESULTS
1Q16 FINANCIAL RESULTS Towards the execution of our plan Warsaw, 10 May 2016 Disclaimer This presentation (the Presentation ) has been prepared by Bank Polska Kasa Opieki Spółka Akcyjna ( Bank ) for the
More informationLeading Intimate Healthcare
21 May 2008 1 Leading Intimate Healthcare Investor presentation H1 2007/08 2 Agenda Introduction to Coloplast First 6 months 2007/08 in headlines Outlook for 2007/08 Strategic targets Leading intimate
More informationPresentation First quarter 2006
Immunity for Life TM Presentation First quarter 2006 CEO Gunnar Rørstad CFO Finn Samuelsen 10 May 2006 Highlights - operations Inclusion of patients almost completed in the the phase II clinical trial
More informationCompany Overview February 26, 2019
Company Overview February 26, 2019 SAFE HARBOR Cautionary Note Regarding Forward-Looking Statements Certain statements in this presentation constitute forward-looking statements, including, without limitation,
More informationValue creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO
Value creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO Coloplast has four business areas all with global sales presence Group revenue
More informationEnel Américas 1Q 2018 results
Enel Américas 1Q 2018 results 1Q 2018 results Highlights of the period EBITDA of 820 musd, an increase of 26% vs 1Q 2017 Generation EBITDA increased by 17% due to better prices in Argentina and consolidation
More informationKey figures (consolidated)
Nestlé Group 2013 Key figures (consolidated) In millions of CHF (except for data per share) 2013 Results Sales 92158 Trading operating profit 14047 as % of sales 15.2% Profit for the year attributable
More informationHow Residential Development Gets Financed
How Residential Development Gets Financed Raquel Favela, Chief of Economic Development & Neighborhood Services Jackie Rodarte, Assistant Director, Housing & Neighborhood Revitalization 1 Understanding
More informationBANK HANDLOWY W WARSZAWIE S.A. 1Q 2009 consolidated financial results -1-
BANK HANDLOWY W WARSZAWIE S.A. 1Q 29 consolidated financial results -1- Macroeconomic situation in 1Q 29 Deep drop in industrial output in January and February, albeit business confidence indicators suggest
More informationVITROLIFE AB (PUBL) NORDEA Small & Mid Cap Seminar
VITROLIFE AB (PUBL) NORDEA Small & Mid Cap Seminar 2018-08-16 1 2 10 15 % OF ALL COUPLES IN FERTILE AGE SUFFER FROM FERTILITY PROBLEMS LEADING COMPANY IN MEDICAL DEVICES FOR ASSISTED REPRODUCTION A Swedish
More informationLetter to Shareholders SEMI-ANNUAL REPORT 2008
Letter to Shareholders SEMI-ANNUAL REPORT 2008 Dear Shareholder You have in your hand the first shareholder letter issued by Nobel Biocare. Thanks to the conversion of Nobel Biocare s bearer shares into
More informationThird Quarter 2017 NCREIF Indices Review. Fall Conference November 7, 2017
Third Quarter 2017 NCREIF Indices Review Fall Conference November 7, 2017 Panelist Overview Jeff Fisher NCREIF Data & Research Consultant Sara Rutledge NCREIF Director of Research John Ehli Portfolio Manager
More informationColoplast A/S. Carnegie Nordic Healthcare Seminar 31 May - 1 June
Coloplast A/S Carnegie Nordic Healthcare Seminar 31 May - 1 June 2 Coloplast Coloplast products and services help patients achieve greater independence from medical challenges in 5 areas: Ostomy care,
More informationVITROLIFE AB (PUBL) Pareto Securities Health Care Conference
VITROLIFE AB (PUBL) Pareto Securities Health Care Conference 2018-09-06 1 2 10 15 % OF ALL COUPLES IN FERTILE AGE SUFFER FROM FERTILITY PROBLEMS LEADING COMPANY IN MEDICAL DEVICES FOR ASSISTED REPRODUCTION
More informationADM to Acquire Neovia and Probiotics International Limited. July 2, 2018
ADM to Acquire Neovia and Probiotics International Limited July 2, 2018 Safe Harbor Statement 2 Some of our comments constitute forward-looking statements that reflect management s current views and estimates
More informationResults Briefing. 15 ~ 17 May 2007
Results Briefing 1Q Q & 3 Months ended 31 Mar. 2007 15 ~ 17 May 2007 Content Key highlights Financial Corporate Financial results Industry overview Q&A Appendix 2 2 Key Highlights for the Period Key Highlights
More informationGlobal Invisible Braces Market: Trends, Opportunities and Forecasts ( )
Global Invisible Braces Market: Trends, Opportunities and Forecasts (2016-2021) By Types Clear Aligners, Ceramic, Lingual By Region Americas, Europe, Middle East, Africa, Asia-Pacific By Country- USA,
More informationConsolidated: Financial Summary
FY2010 First Quarter Financial Results SUZUKI MOTOR CORPORATION 3 August 2010 Consolidated: Financial Summary Page2 FY2010 1Q FY2009 1Q (2010/4-6) (2009/4-6) Change Net sales 656.3 577.1 +79.2 +13.7% Operating
More informationSumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical
For immediate release November 25, 2004 Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical Sumitomo Chemical Co., Ltd. announced today that its subsidiary, Sumitomo
More information2010 First Quarter Results Presentation. 11 th May 2010
2010 First Quarter Results Presentation 11 th May 2010 1 Broadcasting 2 ITALY TV Consumption trend (2003-2010) Average Daily minutes 271 273 270 270 Individuals 269 266 255 250 251 245 251 256 245 244
More informationASL MARINE. DBS Vickers Pulse of Asia Roadshow 10 January 2012
ASL MARINE DBS Vickers Pulse of Asia Roadshow 10 January 2012 Presentation Outline Group Overview 1Q FY2012 Financial Review (3 months ended 30 September 2011) Operations Review - Shipbuilding - Shiprepair
More informationImmunity for Life TM. Third Quarter CEO Lars Viksmoen CFO Finn Samuelsen. 31 October 2007
Immunity for Life TM Third Quarter 2007 CEO Lars Viksmoen CFO Finn Samuelsen 31 October 2007 Operational Highlights for Q3 2007 Clinical phase III study with SBG for treatment of diabetic ulcers; enrolment
More informationP.L.A.Y. Feasibility Study Report. May 2007
P.L.A.Y. Feasibility Study Report May 2007 Design Team Treanor Architects, P.A. Green Play LLC Landplan Engineering P.A. Richard Caplan and Associates Leisure Vision/ETC Document Needs Feasibility Study
More informationVestavia Hills, City of, AL
Vestavia Hills, City of, AL 1 City of Vestavia Hills, Alabama, General Obligation Warrants, Series 2016, $11,810,000, Dated: July 14, 2016 2 City of Vestavia Hills, Alabama, General Obligation Warrants,
More informationTo be the partner of choice Straumann
To be the partner of choice Straumann Gilbert Achermann, CEO Helvea Swiss Equities Conference 11 January 2008, Bad Ragaz Table of contents 1. A snapshot of Straumann 2. Financials 3. Markets and opportunities
More informationFINANCIAL RESULTS 1H 2016 Growth in key volumes and core revenues
FINANCIAL RESULTS 1H 2016 Growth in key volumes and core revenues Warsaw, 03.08.2016 Disclaimer This presentation (the Presentation ) has been prepared by Bank Polska Kasa Opieki Spółka Akcyjna ( Bank
More informationTHIRD QUARTER REPORT 2011 (UNAUDITED)
THIRD QUARTER REPORT 2011 (UNAUDITED) Kronprinsesse Märthas pl. 1, Vika, 0166 Oslo, Norway. Tel: + 47 23 01 09 60, www.bionorpharma.com Page 1 THIRD QUARTER REPORT 2011 HIGHLIGHTS On the 25th August Bionor
More informationAnnual Figures 2017/18. Burgdorf, 24 May 2018
Annual Figures 2017/18 Burgdorf, 24 May 2018 Important information The information contained in this document has not been verified by an independent source. It should be taken with caution and no assurance
More informationWalgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs
Walgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs Second quarter sales up 3.1 percent to record $17.0 billion
More informationTotal Face Group Limited
Total Face Group Limited 2017 Half Year Results Presentation Contents Results Highlights Highlights Half Year Results Revenue Bridge Revenue Breakdown Clinic Profitability Profit & Loss Financial Position
More informationFor personal use only
Cedar Woods Properties Limited EUROZ INVESTOR CONFERENCE 14 March 2017 Cedar Woods strategy Cedar Woods Presentation 2 To grow and develop our national project portfolio, diversified by: geography product
More informationFINANCIAL RESULTS 1H 2015 Core revenues supporting 2015 plan delivery
FINANCIAL RESULTS 1H 2015 Core revenues supporting 2015 plan delivery Warsaw, 04.08.2015 Disclaimer This presentation (the Presentation ) has been prepared by Bank Polska Kasa Opieki Spółka Akcyjna ( Bank
More information2017 Annual General Meeting
Cedar Woods Presentation 1 Cedar Woods Properties Limited 2017 Annual General Meeting 9 November 2017 Cedar Woods Presentation 2 Agenda 1 Chairman s Address Mr William G Hames 2 Managing Director s Review
More informationLED Medical Diagnostics Inc. TSXV: LMD / OTCQB:LEDIF
LED Medical Diagnostics Inc. TSXV: LMD / OTCQB:LEDIF WHAT WE DO LED Medical Diagnostics Inc. provides software and imaging device solutions to Dentists, Dental Support Organizations (DSOs) & the US Military
More informationDRONE FOOTAGE AVAILABLE
RITE AID 535 Portland Avenue Rochester, NY Rite Aid #03597 Rochester Click here to view drone video footage of the property! DRONE FOOTAGE AVAILABLE Click here to view drone photos of the property! TABLE
More informationYpsomed Holding AG Semiannual Report 2018 / 19
Ypsomed Holding AG Semiannual Report 2018 / 19 The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over
More informationGlobal Prefilled Syringes Market: Trends, Opportunities and Forecasts ( )
Global Prefilled Syringes Market: Trends, Opportunities and Forecasts (2016-2021) By Material - Glass and Plastic By Filling Capabilities Single Chamber and Dual/Multiple Chamber By Major Applications
More informationSpiros Nomikos Chief Executive Officer Solvay Sodi Bulgaria
Spiros Nomikos Chief Executive Officer Solvay Sodi Bulgaria FINANCIAL TIMES INVESTING IN BULGARIA CONFERENCE Investment Opportunities in Bulgaria The Case of Solvay Sodi Spiros Nomikos CEO of Solvay Sodi
More informationPRICE DEMERS & CO. Barristers, Solicitors & Notaries Public
PRICE DEMERS & CO. Barristers, Solicitors & Notaries Public Incorporation of BVI Business Companies under the BVI Business Companies Act, 2004 1. Introduction The following is a brief summary of the main
More informationNestlé Investor Seminar 2008
Nestlé Investor Seminar 2008 Nestlé Nutrition update on Acquisitions Richard Laube CEO Nestlé Nutrition 1 Disclaimer This presentation contains forward looking statements which reflect Management s current
More informationEUROZ INVESTOR CONFERENCE
Cedar Woods Properties Limited EUROZ INVESTOR CONFERENCE 14 March 2017 Cedar Woods strategy Cedar Woods Presentation 2 To grow and develop our national project portfolio, diversified by: geography product
More informationPublic Expose. Jakarta, 21 December 2012
Public Expose Jakarta, 21 December 2012 Overview Established in 1911 as a plantation and processing natural rubber company, PT Bakrie Sumatera UNSP Sales (IDR Billion) Plantations Tbk ( UNSP ) now evolving
More informationDistribution Partner Briefing: A Partnership for Profit. Welcome to Smartcool s information package for prospective channel partners.
Distribution Partner Briefing: A Partnership for Profit Welcome to Smartcool s information package for prospective channel partners. This publication is intended only as a general guide to assist you in
More informationThe acquisition of Fortitech
The acquisition of Fortitech Accelerating DSM s strategy to become a full solutions provider in food ingredient blends Investor Relations 8 November 2012 Overview Fortitech at a glance Acquisition rationale
More informationAn exciting combination in a high growth, high margin Nutrition category. Name of chairman
An exciting combination in a high growth, high margin Nutrition category 2 Vevey, December 14, 2006 Disclaimer This presentation contains forward looking statements which reflect Management s current views
More informationFor personal use only
HY18 Result Presentation 13 February 2018 Dig Howitt Brent Cubis CEO & President CFO HY18 Result highlights Strong momentum across developed markets continues Developed market unit growth up 12% Strengthening
More informationGroup financial results for the first quarter 2008
Helmut Perlet, Member of the Board of Management Group financial results for the first quarter 2008 Journalists Conference Call May 9th, 2008 Group: robust earnings in stormy weather (EUR mn) Quarterly
More informationDRONE FOOTAGE AVAILABLE
WALGREENS 792 West Main St Rochester, NY Rite Aid #00615 Rochester Walgreens Converted Store Click here to view drone video footage of the property! DRONE FOOTAGE AVAILABLE Click here to view drone photos
More informationColoplast A/S. Goldman Sachs Medtech Conference London, 7-8 September Sten Scheibye, CEO
Coloplast A/S Goldman Sachs Medtech Conference London, 7-8 September 2005 Sten Scheibye, CEO 2 Coloplast Coloplast products and services help patients achieve greater independence from medical challenges
More informationBusiness plan SATIVA GmbH & Co. KG
Business plan SATIVA GmbH & Co. KG Preamble A Import of medicinal-cannabis flowers 1.) Importe from the Netherlands 2.) Importe from Canada and Switzerland 3.) Full extracts from Canada and Switzerland
More informationStrategic Business Overview. Bernard HOURS
Strategic Business Overview Bernard HOURS 2000-2007: Continuous growth 8% Volume 10% Sales 14% EBIT 7% 6% 5% 4% 3% 2% 1% 9% 8% 7% 6% 5% 4% 3% 2% 1% 12% 10% 8% 6% 4% 2% 0% 0% 0% 2000 2007 2000 2007 2000
More information